By Mona Chitre Have you ever wondered why health care spending in the U.S. often exceeds that of other industrialized nations who have health care outcomes similar to ours? It turns out that one reason for this difference is our lack of approved biosimilar medications to compete
Read more →Why Do Drugs Cost So Much? And What Can We Do? By Mona Chitre and Matthew Bartels In the United States, the average price of brand-name drugs has increased 98.2 percent since 2011, according to Express Scripts, a pharmacy benefit management company that partners with health insurers
Read more →
